Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant Prostate Cancer (CRPC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06842498
What this trial is testing

FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Kyntra Bio 75
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Testing effectiveness (Phase 2)Study completedNCT02344017
What this trial is testing

Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 23
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Early research (Phase 1)Not Yet RecruitingNCT07683013
What this trial is testing

Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Hyundai Bioscience Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05534646
What this trial is testing

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Edwin Posadas, MD 100
Large-scale testing (Phase 3)Ended earlyNCT02057666
What this trial is testing

Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Ipsen 146
Testing effectiveness (Phase 2)Study completedNCT02384382
What this trial is testing

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
Pfizer 23
Early research (Phase 1)Looking for participantsNCT06705686
What this trial is testing

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma
TechnoGenesys, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04157088
What this trial is testing

Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Bayer 30
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Testing effectiveness (Phase 2)Ended earlyNCT01338012
What this trial is testing

Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 8
Early research (Phase 1)Study completedNCT01911741
What this trial is testing

Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects

Who this might be right for
Healthy SubjectsCastration Resistant Prostate Cancer (CRPC)Relative Bioavailability+1 more
Astellas Pharma Europe B.V. 55
Testing effectiveness (Phase 2)Looking for participantsNCT07745361
What this trial is testing

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate CancerProstate Cancer+1 more
Monte Rosa Therapeutics, Inc 25
Testing effectiveness (Phase 2)Looking for participantsNCT07259213
What this trial is testing

Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd 73
Early research (Phase 1)Looking for participantsNCT07007910
What this trial is testing

Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
m CRPC
Haisco Pharmaceutical Group Co., Ltd. 90
Testing effectiveness (Phase 2)WithdrawnNCT00577980
What this trial is testing

Testosterone in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03329742
What this trial is testing

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Indiana University 2
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Next Page